CapitolMarkets
Josh Gottheimer
Josh Gottheimer
DHouseRepresentative · New Jersey

Sold up to $15,000 of AbbVie (ABBV)

Trade dated May 5, 202629 days to disclose
ABBV since the sale
+9.1%
S&P 500, same window
+4.6%
ABBV beat the S&P 500 by 4.5 points since the sale

Price move from the trade date's close to the most recent close. A sale is favorable when the stock fell after.

On the public record around this trade

Committee activity, sponsored or cosponsored bills, and floor votes in this sector within 90 days — alongside the trade and its disclosure. Dated public record; draw your own conclusions.

  1. Apr 16, 2026Floor vote
    Result: Passed
  2. Apr 21, 2026Floor vote
    Result: Passed
  3. Apr 27, 2026Floor vote
    Result: Passed
  4. Apr 28, 2026Legislation
    Pharmaceutical sector
  5. Apr 29, 2026Legislation
    Pharmaceutical sector
  6. May 4, 2026Legislation
    Pharmaceutical sector
  7. May 5, 2026Trade
    Sold up to $15,000 of ABBV
  8. May 13, 2026Legislation
    Pharmaceutical sector
  9. May 15, 2026Legislation
    Pharmaceutical sector
  10. May 20, 2026Committee
    Partnering for Innovation: How Bank-Fintech Collaborations Enhance Financial Infrastructure
  11. May 20, 2026Committee
    From Order to Execution: Ensuring Efficient and Transparent Equity Markets
  12. May 21, 2026Committee
    Modernizing the BSA for Financial Crime in the 21st Century
  13. Jun 3, 2026Disclosure
    Disclosed the trade
    Public filing
View the original filing (PDF)Source: U.S. House Clerk (disclosures-clerk.house.gov)
Get an alert the moment Josh Gottheimer files the next one

Capitol Markets tracks every Member of Congress in plain English — the trade, the price move, the committee overlap, the source filing.